Exclusive Interview - Dr. Mark McCamish, Global Head of Biopharmaceutical Development, Sandoz

Image Source

The 13th Annual Business of Biosimilars & Generic Drugs offers you access to an exclusive interview with Dr. Mark McCamish, Global Head of Biopharmaceutical Development at Sandoz.

Dr. McCamish’s remarks cover such key topics as:

• • The critical role biosimilars can play in increasing access and lowering healthcare costs
• • Key takeaway points in the current FDA Draft Guidelines on biosimilar development.
• • Implications of using unique names to identify biosimilars
• • Importance of communication in building acceptance and understanding of biosimilars

Download download the interview.

The 13th Annual Business of Biosimilars and Generic Drugs Event will take place September 10-12, 2012 in Boston, MA. As a reader of the Future of Biopharma blog, you receive an exclusive discount of 25% off of the standard price when you register to join us and use priority code XP1786BLOG.  For more information on this year's program, download the brochure here.  Have any questions about the event? Feel free to contact Jennifer Pereira.

Share this article with your social network, just click below to share now!

Share |